<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: cardiac failure</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Study suggests new role for ECMO in treating patients with cardiac arrest and profound shock</title>
   	 <description>Extracorporeal membrane oxygenation (ECMO), a procedure traditionally used during cardiac surgeries and in the ICU that functions as an artificial replacement for a patient's heart and lungs, has also been used to resuscitate cardiac arrest victims in Japan, Taiwan, and South Korea. Now, a novel study of this technique in the U.S. has been completed by researchers at the Perelman School of Medicine at the University of Pennsylvania, indicating a potential role for this intervention to save patients who are unable to be resuscitated through conventional measures. The new findings will be presented at the Society for Academic Emergency Medicine annual meeting in Atlanta, Ga.</description>
     <link>http://medicalxpress.com/news/2013-05-role-ecmo-patients-cardiac-profound.html</link>
	 <category>Cardiology</category>
	 <pubDate>Fri, 17 May 2013 09:50:01 EST</pubDate>
	 <guid isPermaLink="false">news288002074</guid>
	 
</item>
<item>
     <title>Anti-ageing drug breakthrough</title>
   	 <description>Drugs that combat ageing may be available within five years, following landmark work led by an Australian researcher. The work, published in the March 8 issue of Science, finally proves that a single anti-ageing enzyme in the body can be targeted, with the potential to prevent age-related diseases and extend lifespans.</description>
     <link>http://medicalxpress.com/news/2013-03-anti-ageing-drug-breakthrough.html</link>
	 <category>Medical research</category>
	 <pubDate>Fri, 08 Mar 2013 08:10:59 EST</pubDate>
	 <guid isPermaLink="false">news281952653</guid>
	 
</item>
<item>
     <title>Scientists discover 'needle in a haystack' for muscular dystrophy patients</title>
   	 <description>(Medical Xpress)—Muscular dystrophy is caused by the largest human gene, a complex chemical leviathan that has confounded scientists for decades. Research conducted at the University of Missouri and described this month in the Proceedings of the National Academy of Sciences has identified significant sections of the gene that could provide hope to young patients and families.</description>
     <link>http://medicalxpress.com/news/2013-01-scientists-needle-haystack-muscular-dystrophy.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 22 Jan 2013 15:11:27 EST</pubDate>
	 <guid isPermaLink="false">news278089867</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/5-scientistsdi.jpg" width="90" height="90" />
</item>
<item>
     <title>Tapping into calcium's role in a healthy heart</title>
   	 <description>Australian scientists are getting closer to decoding the way molecules interact to enable regular heart function.</description>
     <link>http://medicalxpress.com/news/2012-11-calcium-role-healthy-heart.html</link>
	 <category>Cardiology</category>
	 <pubDate>Wed, 21 Nov 2012 08:44:26 EST</pubDate>
	 <guid isPermaLink="false">news272709848</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/111-clipboard-1.jpg" width="90" height="90" />
</item>
<item>
     <title>Discovery may lead to targeted heart disease treatments</title>
   	 <description>University of Guelph researchers have found the location and effect of abnormal heart proteins that can cause cardiac failure, a discovery that points to potential new ways to treat the most costly health problem in the world.</description>
     <link>http://medicalxpress.com/news/2012-05-discovery-heart-disease-treatments.html</link>
	 <category>Cardiology</category>
	 <pubDate>Tue, 08 May 2012 17:00:01 EST</pubDate>
	 <guid isPermaLink="false">news255710608</guid>
	 
</item>
<item>
     <title>Genetic causes found in nearly 1 in 5 patients with dilated cardiomyopathy heart failure</title>
   	 <description>(Medical Xpress) -- Researchers have identified genetic causes in nearly 1 in 5 patients who suffer a type of heart failure called dilated cardiomyopathy.</description>
     <link>http://medicalxpress.com/news/2012-03-genetic-patients-dilated-cardiomyopathy-heart.html</link>
	 <category>Cardiology</category>
	 <pubDate>Tue, 27 Mar 2012 07:52:23 EST</pubDate>
	 <guid isPermaLink="false">news252053513</guid>
	 
</item>
<item>
     <title>Study examines use of bevacizumab among patients with hereditary blood vessel disorder</title>
   	 <description>In a small study that included 25 patients with hereditary hemorrhagic telangiectasia (a genetic disorder that leads to abnormalities of blood vessels) and severe liver involvement with this disease, patients who received the drug bevacizumab had improved cardiac output and a reduction in the duration and number of episodes of nose bleeds, a potentially life-threatening complication for patients with this disorder, according to a study in the March 7 issue of JAMA.</description>
     <link>http://medicalxpress.com/news/2012-03-bevacizumab-patients-hereditary-blood-vessel.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Tue, 06 Mar 2012 16:00:01 EST</pubDate>
	 <guid isPermaLink="false">news250269569</guid>
	 
</item>
<item>
     <title>HFSA updates recommendations for use of cardiac resynchronization therapy</title>
   	 <description>Based on a review of the latest evidence, the Guidelines Committee of the Heart Failure Society of America now recommends that the use of cardiac resynchronization therapy (CRT) be expanded to a larger group of patients with mild heart failure symptoms. Recommendations for integrating new evidence into clinical practice appear in the February issue of the Journal of Cardiac Failure.</description>
     <link>http://medicalxpress.com/news/2012-02-hfsa-cardiac-resynchronization-therapy.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 27 Feb 2012 18:08:54 EST</pubDate>
	 <guid isPermaLink="false">news249588527</guid>
	 
</item>


</channel>
</rss>
